Niche Live Cell Target Live Cell Assays, LLC for contract research and software-enabled imaging services, emphasizing their VSOM system and custom analytical software to drive automated decision-making in live-cell imaging.

Ex Vivo Expansion Leverage their ongoing development of ex vivo VSOM assays for tracking cancer stem cells in Patient Derived Xenograft tissue, presenting opportunities in oncology research collaborations and potential clinical translation partnerships.

Small Team, Big Need With a lean team and private funding posture seeking investors and partners, position as a value-added biotech services provider for larger firms needing specialized imaging analytics, software customization, and flexible CRO capabilities.

VSOM Licensing Explore licensing or co-development arrangements for the patented VSOM methodology and corresponding software to expand market reach, while clarifying commercial use license requirements for customers.

Revenue Growth Capitalize on current revenue range and growth trajectory by targeting mid-to-large biotech, pharmaceutical, and academic customers requiring turnkey live-cell imaging, kinetic analysis, and scalable data analytics solutions.